Literature DB >> 31089972

Addendum to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study.

Daniel R Morales1, Rob Flynn2, Xavier Kurz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31089972     DOI： 10.1007/s40261-019-00792-7

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  10 in total

1.  Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.

Authors:  Mahyar Etminan; James M Brophy; Ali Samii
Journal:  Neurology       Date:  2014-08-22       Impact factor: 9.910

2.  A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections.

Authors:  Colin Murray; Arlene Shaw; Matthew Lloyd; Robin P Smith; Thomas C Fardon; Stuart Schembri; James D Chalmers
Journal:  J Antimicrob Chemother       Date:  2013-09-10       Impact factor: 5.790

3.  Oral Fluoroquinolone and the Risk of Aortic Dissection.

Authors:  Chien-Chang Lee; Meng-Tse Gabriel Lee; Ronan Hsieh; Lorenzo Porta; Wan-Chien Lee; Si-Huei Lee; Shy-Shin Chang
Journal:  J Am Coll Cardiol       Date:  2018-09-18       Impact factor: 24.094

4.  Short-Term Risk of Aortoiliac Aneurysm or Dissection Associated With Fluoroquinolone Use.

Authors:  Sandy Maumus-Robert; Xavier Bérard; Yohann Mansiaux; Pascale Tubert-Bitter; Stéphanie Debette; Antoine Pariente
Journal:  J Am Coll Cardiol       Date:  2019-02-26       Impact factor: 24.094

5.  Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.

Authors:  Daniel Morales; Alexandra Pacurariu; Jim Slattery; Luis Pinheiro; Patricia McGettigan; Xavier Kurz
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

6.  Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis.

Authors:  G Choudhury; P Mandal; A Singanayagam; A R Akram; J D Chalmers; A T Hill
Journal:  Clin Microbiol Infect       Date:  2011-09-15       Impact factor: 8.067

7.  Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.

Authors:  Daniel R Morales; Jim Slattery; Luis Pinheiro; Xavier Kurz; Karin Hedenmalm
Journal:  Clin Drug Investig       Date:  2018-10       Impact factor: 2.859

8.  Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the effect with and without corticosteroids.

Authors:  Rebecca Persson; Susan Jick
Journal:  Br J Clin Pharmacol       Date:  2019-03-18       Impact factor: 4.335

9.  Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study.

Authors:  Björn Pasternak; Malin Inghammar; Henrik Svanström
Journal:  BMJ       Date:  2018-03-08

10.  Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study.

Authors:  Daniel R Morales; Jim Slattery; Alexandra Pacurariu; Luis Pinheiro; Patricia McGettigan; Xavier Kurz
Journal:  Clin Drug Investig       Date:  2019-02       Impact factor: 2.859
  10 in total
  2 in total

1.  "Ciprofloxacin-induced" bilateral quadriceps tendon rupture: A case report and conclusions of the recent literature.

Authors:  Cyrill Suter; Harald Leemann; Reto Twerenbold
Journal:  Trauma Case Rep       Date:  2021-02-10

2.  Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.

Authors:  Daniel R Morales; Alexandra Pacurariu; Jim Slattery; Xavier Kurz
Journal:  Br J Clin Pharmacol       Date:  2020-03-02       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.